To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Similar clinical outcomes between PAI with liposomal bupivacaine and continuous FNB following TKA

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
April 2019

Similar clinical outcomes between PAI with liposomal bupivacaine and continuous FNB following TKA

Vol: 8| Issue: 4| Number:29| ISSN#: 2564-2537
Study Type:Randomized Trial
OE Level Evidence:2
Journal Level of Evidence:N/A

Periarticular Knee Injection With Liposomal Bupivacaine and Continuous Femoral Nerve Block for Postoperative Pain Management After Total Knee Arthroplasty: A Randomized Controlled Trial

J Arthroplasty. 2019 Mar;34(3):495-500.

Contributing Authors:
J Marino G Scuderi O Dowling R Farquhar B Freycinet F Overdyk

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

65 patients scheduled for a unilateral total knee arthroplasty were randomized to receive a continuous femoral nerve block (FNB) with bupivacaine or a peri-articular injection with liposomal bupivacaine (EXPAREL). The primary outcome of interest was the pain intensity during maximal knee flexion, specifically at 24 hours. Secondary outcomes included pain intensity at rest, during movement and duri...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue